Catyalyst Pharmaceutical Partners (CPRX) Tops Q2 EPS by 2c

Catyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q2 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07).

For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c